There are many drugs out there that only work for a portion of patients, and personalized medicine approaches aim to direct patients to the drugs that will work for them. But, as the J. Craig Venter Institute's Nicholas Schork writes at Nature, standard clinical trials can't be used to test such personal interventions.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.